RB
Ritu Baral TD Cowen Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
3.4%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
93.8%
Neutral
6.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $37 |
74%
upside
| 2 | -4.7% |
0
%
| 26 Feb ‘26 3 months ago |
|
|
|
Buy
Maintained
| $306 |
6%
downside
| 1 | +0.66% |
0
%
| 9 Jan ‘26 5 months ago |
|
|
|
Buy
Initiated
| $67 |
100%
upside
| 1 | -8.6% |
0
%
| 5 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $241 |
147%
upside
| 4 | +2.1% |
0
%
| 18 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $133 |
14%
upside
| 2 | +30% |
0
%
| 16 Dec ‘25 6 months ago |
|
|
|
Buy
Upgraded
| $8 |
511%
upside
| 1 | -30% |
0
%
| 15 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $353 |
33%
upside
| 1 | +22% |
0
%
| 8 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $73 |
113%
upside
| 1 | -6.7% |
0
%
| 5 Dec ‘25 6 months ago |
|
|
|
Hold
Downgraded
| $74 |
2%
upside
| 1 | -2.9% |
–
| 29 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $554 |
11%
upside
| 1 | +9.5% |
0
%
| 26 Aug ‘25 9 months ago |
|
|
|
Buy
Initiated
| $76 |
39%
upside
| 1 | +13% |
0
%
| 4 Aug ‘25 10 months ago |
|